11 Einträge gefunden

1. Impact of body mass index in patients receiving atezolizumab plus bevacizumab for hepatocellular carcinoma

   1. Vithayathil, Mathew
   2. D'Alessio, Antonio
   3. Fulgenzi, Claudia Angela Maria
   4. Nishida, Naoshi
   5. Schönlein, Martin
   6. von Felden, Johann
   7. Schulze, Kornelius

   2023 - Forschungsinformationssystem des UKE - frei zugänglich
2. Preliminary evidence of safety and tolerability of atezolizumab plus bevacizumab in patients with hepatocellular carcinoma and Child-Pugh A and B cirrhosis: a real-world study

   1. D'Alessio, Antonio
   2. Fulgenzi, Claudia Angela Maria
   3. Nishida, Naoshi
   4. Schönlein, Martin
   5. von Felden, Johann
   6. Schulze, Kornelius
   7. Wege, Henning

   2022 - Forschungsinformationssystem des UKE - frei zugänglich
3. Circulating tumor cells as a preoperative risk marker for occult metastases in patients with resectable cholangiocarcinoma

   1. Fründt, Thorben
   2. von Felden, Johann
   3. Krause, Jenny
   4. Heumann, Asmus
   5. Li, Jun
   6. Riethdorf, Sabine
   7. Pantel, Klaus

   2022 - Forschungsinformationssystem des UKE - frei zugänglich
4. Impact of older age in patients receiving atezolizumab and bevacizumab for hepatocellular carcinoma

   1. Vithayathil, Mathew
   2. D'Alessio, Antonio
   3. Fulgenzi, Claudia Angela Maria
   4. Nishida, Naoshi
   5. Schönlein, Martin
   6. von Felden, Johann
   7. Schulze, Kornelius

   2022 - Forschungsinformationssystem des UKE - frei zugänglich
5. Rare variants of primary liver cancer: Fibrolamellar, combined, and sarcomatoid hepatocellular carcinomas

   1. Wege, Henning
   2. Schulze, Kornelius
   3. von Felden, Johann
   4. Calderaro, Julien
   5. Reig, Maria

   2021 - Forschungsinformationssystem des UKE
6. Diagnostic and Prognostic Value of miR-16, miR-146a, miR-192 and miR-221 in Exosomes of Hepatocellular Carcinoma and Liver Cirrhosis Patients

   1. Fründt, Thorben
   2. Krause, Linda
   3. Hussey, Elaine
   4. Steinbach, Bettina
   5. Köhler, Daniel
   6. von Felden, Johann
   7. Schulze, Kornelius

   2021 - Forschungsinformationssystem des UKE - frei zugänglich
7. Sequential Systemic Treatment in Advanced Hepatocellular Carcinoma Is Able to Prolong Median Survival to More than 3 Years in a Selected Real-World Cohort

   1. von Felden, Johann
   2. Karkmann, Kathrin
   3. Ittrich, Harald
   4. Gil-Ibanez, Ines
   5. Fründt, Thorben
   6. Krause, Jenny
   7. Lohse, Ansgar W

   2021 - Forschungsinformationssystem des UKE - frei zugänglich
8. Elevated Aspartate Aminotransferase to Alanine Aminotransferase Ratio Predicts Poor Outcome in Hepatocellular Carcinoma

   1. von Felden, Johann
   2. Wege, Henning
   3. Schulze, Kornelius

   2020 - Forschungsinformationssystem des UKE
9. High expression of micro RNA-135A in hepatocellular carcinoma is associated with recurrence within 12 months after resection

   1. von Felden, Johann
   2. Heim, Denise
   3. Schulze, Kornelius
   4. Krech, Till
   5. Ewald, Florian
   6. Nashan, Björn
   7. Lohse, Ansgar W

   2017 - Forschungsinformationssystem des UKE - frei zugänglich
10. Circulating tumor cells as liquid biomarker for high HCC recurrence risk after curative liver resection

    1. von Felden, Johann
    2. Schulze, Kornelius
    3. Krech, Till
    4. Ewald, Florian
    5. Nashan, Björn
    6. Pantel, Klaus
    7. Lohse, Ansgar W

    2017 - Forschungsinformationssystem des UKE
11. First- and Second-Line Targeted Systemic Therapy in Hepatocellular Carcinoma-An Update on Patient Selection and Response Evaluation

    1. von Felden, Johann
    2. Schulze, Kornelius
    3. Gil-Ibanez, Ines
    4. Werner, Tobias
    5. Wege, Henning

    2016 - Forschungsinformationssystem des UKE - frei zugänglich